MX387200B - Extracto de streptococcus uberis como agente inmunogénico. - Google Patents
Extracto de streptococcus uberis como agente inmunogénico.Info
- Publication number
- MX387200B MX387200B MX2018009048A MX2018009048A MX387200B MX 387200 B MX387200 B MX 387200B MX 2018009048 A MX2018009048 A MX 2018009048A MX 2018009048 A MX2018009048 A MX 2018009048A MX 387200 B MX387200 B MX 387200B
- Authority
- MX
- Mexico
- Prior art keywords
- relates
- immunogenic agent
- biofilm
- agent
- extract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16382060 | 2016-02-15 | ||
| PCT/EP2017/053306 WO2017140683A2 (en) | 2016-02-15 | 2017-02-14 | Streptococcus uberis extract as an immunogenic agent |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2018009048A MX2018009048A (es) | 2019-03-28 |
| MX387200B true MX387200B (es) | 2025-03-18 |
Family
ID=55646514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2018009048A MX387200B (es) | 2016-02-15 | 2017-02-14 | Extracto de streptococcus uberis como agente inmunogénico. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10946085B2 (enExample) |
| EP (1) | EP3417049B1 (enExample) |
| JP (1) | JP6839199B2 (enExample) |
| KR (1) | KR102824686B1 (enExample) |
| AU (1) | AU2017220528A1 (enExample) |
| CA (1) | CA3012419A1 (enExample) |
| ES (1) | ES2960326T3 (enExample) |
| MX (1) | MX387200B (enExample) |
| PL (1) | PL3417049T3 (enExample) |
| WO (1) | WO2017140683A2 (enExample) |
| ZA (1) | ZA201805039B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2022352157A1 (en) | 2021-09-21 | 2024-05-02 | National Agriculture And Food Research Organization | Vaccine including nonencapsulated strain as antigen |
| EP4570265A1 (en) | 2023-12-15 | 2025-06-18 | Zaklad Badawczo-Wdrozeniowy Osrodka Salmonella "Immunolab" Sp. z o.o. | Vaccine for use in preventing inflammatory conditions in cows |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60243024A (ja) * | 1983-12-29 | 1985-12-03 | Kitasato Inst:The | ストレプトコツカス・サンギス感染症予防用ワクチン,診断用抗原および抗体 |
| CA2059693C (en) * | 1991-01-28 | 2003-08-19 | Peter J. Kniskern | Polysaccharide antigens from streptococcus pneumoniae |
| CA2222701C (en) | 1995-06-08 | 2012-02-07 | University Of Saskatchewan | Camp factor of streptococcus uberis |
| DK1332155T3 (da) | 2000-06-12 | 2007-02-26 | Univ Saskatchewan | Vaccination af malkekvæg med GapC protein mod streptokokinfektion |
| US20070231335A1 (en) * | 2005-07-20 | 2007-10-04 | Bruce Beutler | Compositions and methods for treating Gram positive bacterial infection in a mammalian subject |
| US8273361B2 (en) | 2006-09-26 | 2012-09-25 | Infectious Disease Research Institute | Vaccine composition containing synthetic adjuvant |
| US20110028407A1 (en) * | 2007-02-09 | 2011-02-03 | Jutila Mark A | Enhancement of innate resistance to infection |
| GB0818231D0 (en) | 2008-10-06 | 2008-11-12 | Univ Nottingham | Composition |
| EP3461496B1 (en) * | 2009-06-22 | 2023-08-23 | Wyeth LLC | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| WO2012116447A1 (en) | 2011-03-03 | 2012-09-07 | The Governors Of The University Of Alberta | Use of bacterial endotoxins and lipoteichoic acids to improve postpartal health and productivity of dairy cows and their newborns |
| MX2013013182A (es) | 2011-05-12 | 2013-12-09 | Intervet Int Bv | Tratamiento de la mastitis. |
| BR112013032675A2 (pt) * | 2011-06-19 | 2017-08-08 | Vaxine Pty Ltd | composição adjuvante de vacina compreendendo partículas de inulina |
| WO2015042423A2 (en) | 2013-09-19 | 2015-03-26 | Zoetis Llc | Vaccine |
-
2017
- 2017-02-14 CA CA3012419A patent/CA3012419A1/en active Pending
- 2017-02-14 AU AU2017220528A patent/AU2017220528A1/en not_active Abandoned
- 2017-02-14 KR KR1020187021575A patent/KR102824686B1/ko active Active
- 2017-02-14 MX MX2018009048A patent/MX387200B/es unknown
- 2017-02-14 PL PL17704038.3T patent/PL3417049T3/pl unknown
- 2017-02-14 JP JP2018538841A patent/JP6839199B2/ja active Active
- 2017-02-14 WO PCT/EP2017/053306 patent/WO2017140683A2/en not_active Ceased
- 2017-02-14 ES ES17704038T patent/ES2960326T3/es active Active
- 2017-02-14 EP EP17704038.3A patent/EP3417049B1/en active Active
- 2017-02-14 US US16/075,092 patent/US10946085B2/en active Active
-
2018
- 2018-07-26 ZA ZA2018/05039A patent/ZA201805039B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102824686B1 (ko) | 2025-06-25 |
| EP3417049A2 (en) | 2018-12-26 |
| PL3417049T3 (pl) | 2024-02-19 |
| CA3012419A1 (en) | 2017-08-24 |
| WO2017140683A2 (en) | 2017-08-24 |
| ZA201805039B (en) | 2020-05-27 |
| JP6839199B2 (ja) | 2021-03-03 |
| ES2960326T3 (es) | 2024-03-04 |
| US20190038736A1 (en) | 2019-02-07 |
| MX2018009048A (es) | 2019-03-28 |
| KR20180108619A (ko) | 2018-10-04 |
| JP2019504623A (ja) | 2019-02-21 |
| AU2017220528A1 (en) | 2018-08-09 |
| EP3417049B1 (en) | 2023-08-16 |
| BR112018015255A2 (pt) | 2018-12-18 |
| WO2017140683A3 (en) | 2017-10-12 |
| US10946085B2 (en) | 2021-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112018068593A2 (pt) | composições tópicas não aquosas que compreendem uma salicilanilida halogenada | |
| EP4477662A3 (en) | Nucleic acid molecules and uses thereof | |
| MX395525B (es) | Composiciones inmunogenicas para usar en vacunas neumococicas. | |
| NZ759686A (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| MX2017015881A (es) | Formulaciones para vacunas contra la neoplasia y metodos para preparar las mismas. | |
| EA201890747A1 (ru) | Способы лечения воспалительных заболеваний | |
| EA201500054A1 (ru) | Аттенуированные вакцины против streptococcus suis и способы их получения и применения | |
| PH12016501988A1 (en) | Antibacterial compounds | |
| MX381211B (es) | Metodos para usar formulaciones para vacuna con microagujas para elicitar en animales inmunidad protectora contra virus de la rabia. | |
| BR112016023613A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| MX378266B (es) | Inhibidores de gingipaina de lisina. | |
| BR112018015367A2 (pt) | carreadores oromucosais de nanofibra para tratamento terapêutico | |
| TN2016000435A1 (en) | Novel macrocyclic compounds. | |
| BR112016024096A2 (pt) | novo bacteriófago e composição compreendendo o mesmo | |
| MX2018008640A (es) | Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano. | |
| CL2019001649A1 (es) | Método para el control de enfermedades bacterianas de plantas utilizando derivados de carboxamida. | |
| MX2022003871A (es) | Composiciones inmunogénicas. | |
| PH12019500570A1 (en) | Ketone inhibitors of lysine gingipain | |
| MX387200B (es) | Extracto de streptococcus uberis como agente inmunogénico. | |
| BR112016030728A2 (pt) | método para tratar ou prevenir uma inflamação induzida por bactérias em um indivíduo, composição imunogênica, composição farmacêutica, uso da composição imunogênica, método para produzir uma composição imunogênica, e, método para tratar ou prevenir uma doença | |
| BR112016029619A2 (pt) | novas fluoroquinolonas e sesu usos no tratamento de infecções bacterianas | |
| MX394066B (es) | Nuevos compuestos | |
| MX387201B (es) | Composiciones para el tratamiento contra infecciones. | |
| BR112018012033A2 (pt) | composição imunogênica e método para detectar infecção por h. pylori em um sujeito | |
| BR112016009076A2 (pt) | Composição, processos para preparar um compósito de fluoreto de cálcio e uma composição imunogênica, e, métodos para tratamento ou prevenção de uma infecção ou uma doença causada por vírus, bactéria ou parasita e para induzir uma resposta imunogênica em um humano |